Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

S-8921: specific inhibitor of ileal bile acid transport for hypercholesterolemia

March 2, 1998

ProLease formulation of erythropoietin covered by U.S. patent

Feb. 27, 1998

Development candidate selected by Fujisawa from ACAT inhibitor series

Feb. 27, 1998

Noven and Novartis to collaborate on Vivelle

Feb. 27, 1998

Xenical scheduled for FDA advisory panel review

Feb. 26, 1998

Ergo Science establishes Ergoset partnership with J&J units

Feb. 26, 1998

Merck describes newly discovered beta3-adrenoceptor agonists

Feb. 26, 1998

Nonsteroidal human progesterone receptor agonists developed at Ligand

Feb. 25, 1998

Osiris and the University of Cincinnati expand collaboration in tendon regeneration

Feb. 25, 1998

HFE: a new therapeutic target for iron overload disorders and cancer

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...